NCT03054428 - Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis | Biotech Hunter

Enrollment

251

Participants

Timeline

Start Date

March 21, 2017

Primary Completion Date

April 4, 2018

Study Completion Date

June 5, 2018

Conditions

Moderate-to-Severe Atopic DermatitisDermatitis, Dermatitis AtopicEczema, Skin Diseases, SkinDiseases Genetic, GeneticDiseases Inborn, SkinDisease, Eczematous SkinHypersensitivity, ImmediateHypersensitivity, Immune System DiseasesDermatitis, Atopic

Interventions

DRUG

Dupilumab

Subcutaneous injection among the different quadrants of the abdomen (avoiding navel and waist areas), upper thighs, and upper arms.

DRUG

Placebo

Subcutaneous injection among the different quadrants of the abdomen (avoiding navel and waist areas), upper thighs, and upper arms.

Trial Locations (45)

10029

Regeneron Investigational Site, New York

11375

Regeneron Investigational Site, Forest Hills

14642

Regeneron Investigational Site, Rochester

19104

Regeneron Investigational Site, Philadelphia

20016

Regeneron Investigational Site, Washington D.C.

20850

Regeneron Investigational Site, Rockville

23502

Regeneron Investigational Site, Norfolk

27516

Regeneron Investigational Site, Chapel Hill

29407

Regeneron Investigational Site, Charleston

30328

Regeneron Investigational Site, Sandy Springs

31217

Regeneron Investigational Site, Macon

33624

Regeneron Investigational Site, Tampa

35209

Regeneron Investigational Site, Birmingham

43209

Regeneron Investigational Site, Bexley

46168

Regeneron Investigational Site, Plainfield

46256

Regeneron Investigational Site, Indianapolis

47713

Regeneron Investigational Site, Evansville

55441

Regeneron Investigational Site, Plymouth

60611

Regeneron Investigational Site, Chicago

63110

Regeneron Investigational Site, St Louis

74136

Regeneron Investigational Site, Tulsa

77401

Regeneron Investigational Site, Bellaire

78218

Regeneron Investigational Site, San Antonio

80112

Regeneron Investigational Site, Centennial

80206

Regeneron Investigational Site, Denver

85234

Regeneron Investigational Site, Gilbert

90274

Regeneron Investigational Site, Rolling Hills Estates

90808

Regeneron Investigational Site, Long Beach

92123

Regeneron Investigational Site, San Diego

93309

Regeneron Investigational Site, Bakersfield

95403

Regeneron Investigational Site, Santa Rosa

97223

Regeneron Investigational Site, Portland

97239

Regeneron Investigational Site, Portland

98105

Regeneron Investigational Site, Seattle

02111

Regeneron Investigational Site, Boston

02115

Regeneron Investigational Site, Boston

T2G 1B1

Regeneron Investigational Site, Calgary

V3R 6A7

Regeneron Investigational Site, Surrey

V3V 0C6

Regeneron Investigational Site, Surrey

R3C 0N2

Regeneron Investigational Site, Winnipeg

L3P 1X2

Regeneron Investigational Site, Markham

K2G 6E2

Regeneron Investigational Site, Ottawa

K9J 5K2

Regeneron Investigational Site, Peterborough

L4C9M7

Regeneron Research Site, Richmond Hill

N8W 1E6

Regeneron Investigational Site, Windsor